Profound Medical Corp. (PROF) Tops Q1 EPS by 65c

Profound Medical Corp. (NASDAQ: PROF) reported Q1 EPS of $0.36, $0.65 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.62 million versus the consensus estimate of $3.37 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Ticketplus files for IPO with shares priced between $13-$15
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders